VanEck Associates
BIIB icon

VanEck Associates’s Biogen BIIB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$135M Buy
1,074,811
+1,189
+0.1% +$149K 0.15% 125
2025
Q1
$147M Buy
1,073,622
+7,162
+0.7% +$980K 0.19% 116
2024
Q4
$163M Buy
1,066,460
+967,523
+978% +$148M 0.21% 108
2024
Q3
$18.1M Sell
98,937
-823,824
-89% -$151M 0.02% 323
2024
Q2
$214M Sell
922,761
-814,579
-47% -$189M 0.3% 77
2024
Q1
$375M Buy
1,737,340
+316,144
+22% +$68.2M 0.57% 55
2023
Q4
$368M Buy
1,421,196
+231,650
+19% +$59.9M 0.67% 48
2023
Q3
$306M Buy
1,189,546
+233,889
+24% +$60.1M 0.67% 37
2023
Q2
$272M Buy
955,657
+145,279
+18% +$41.4M 0.6% 47
2023
Q1
$225M Buy
810,378
+22,820
+3% +$6.34M 0.51% 46
2022
Q4
$218M Sell
787,558
-130,428
-14% -$36.1M 0.56% 40
2022
Q3
$245M Sell
917,986
-31,849
-3% -$8.5M 0.73% 32
2022
Q2
$194M Buy
949,835
+11,957
+1% +$2.44M 0.51% 42
2022
Q1
$198M Buy
937,878
+138,949
+17% +$29.3M 0.41% 59
2021
Q4
$192M Buy
798,929
+158,854
+25% +$38.1M 0.44% 61
2021
Q3
$181M Buy
640,075
+43,528
+7% +$12.3M 0.46% 55
2021
Q2
$207M Sell
596,547
-27,497
-4% -$9.52M 0.49% 43
2021
Q1
$175M Buy
624,044
+107,220
+21% +$30M 0.47% 46
2020
Q4
$127M Buy
516,824
+81,406
+19% +$19.9M 0.37% 58
2020
Q3
$124M Buy
435,418
+49,103
+13% +$13.9M 0.39% 46
2020
Q2
$103M Buy
386,315
+37,434
+11% +$10M 0.36% 45
2020
Q1
$110M Sell
348,881
-60,015
-15% -$19M 0.56% 30
2019
Q4
$121M Buy
408,896
+46,897
+13% +$13.9M 0.47% 35
2019
Q3
$84.3M Buy
361,999
+51,931
+17% +$12.1M 0.4% 45
2019
Q2
$72.5M Buy
310,068
+60,339
+24% +$14.1M 0.35% 51
2019
Q1
$59M Buy
249,729
+34,036
+16% +$8.05M 0.29% 75
2018
Q4
$64.9M Buy
215,693
+9,644
+5% +$2.9M 0.33% 55
2018
Q3
$72.8M Sell
206,049
-7,859
-4% -$2.78M 0.36% 65
2018
Q2
$62.1M Buy
213,908
+9,806
+5% +$2.85M 0.29% 78
2018
Q1
$55.9M Sell
204,102
-23,802
-10% -$6.52M 0.28% 79
2017
Q4
$72.6M Sell
227,904
-7,578
-3% -$2.41M 0.36% 70
2017
Q3
$73.7M Sell
235,482
-21,295
-8% -$6.67M 0.38% 63
2017
Q2
$69.7M Buy
256,777
+7,906
+3% +$2.15M 0.38% 61
2017
Q1
$68M Buy
248,871
+36,159
+17% +$9.89M 0.3% 73
2016
Q4
$60.3M Buy
212,712
+13,339
+7% +$3.78M 0.3% 76
2016
Q3
$62.4M Sell
199,373
-7,341
-4% -$2.3M 0.29% 75
2016
Q2
$50M Sell
206,714
-39,262
-16% -$9.49M 0.26% 71
2016
Q1
$64M Sell
245,976
-13,844
-5% -$3.6M 0.43% 54
2015
Q4
$79.6M Buy
259,820
+93,333
+56% +$28.6M 0.63% 41
2015
Q3
$48.6M Buy
166,487
+9,355
+6% +$2.73M 0.37% 67
2015
Q2
$63.5M Sell
157,132
-2,253
-1% -$910K 0.38% 72
2015
Q1
$67.3M Buy
159,385
+24,606
+18% +$10.4M 0.39% 69
2014
Q4
$45.8M Sell
134,779
-3,925
-3% -$1.33M 0.28% 98
2014
Q3
$45.9M Sell
138,704
-13,788
-9% -$4.56M 0.24% 97
2014
Q2
$48.1M Sell
152,492
-15,548
-9% -$4.9M 0.22% 97
2014
Q1
$51.4M Buy
168,040
+22,568
+16% +$6.9M 0.26% 87
2013
Q4
$40.7M Buy
145,472
+8,458
+6% +$2.36M 0.21% 92
2013
Q3
$33M Buy
137,014
+40,299
+42% +$9.7M 0.17% 95
2013
Q2
$20.8M Buy
+96,715
New +$20.8M 0.11% 102